Bio Path Holdings Inc
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in … Read more
Market Cap & Net Worth: Bio Path Holdings Inc (BPTH)
Bio Path Holdings Inc (OTCQX:BPTH) has a market capitalization of $1.65 Million ($1.65 Million) as of March 19, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #36992 globally and #12030 in its home market, demonstrating a 11.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio Path Holdings Inc's stock price $0.18 by its total outstanding shares 9242151 (9.24 Million).
Bio Path Holdings Inc Market Cap History: 2025 to 2025
Bio Path Holdings Inc's market capitalization history from 2025 to 2025. Data shows growth from $1.65 Million to $1.65 Million (0.00% CAGR).
Bio Path Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio Path Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BPTH by Market Capitalization
Companies near Bio Path Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Bio Path Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Bio Path Holdings Inc Historical Marketcap From 2025 to 2025
Between 2025 and today, Bio Path Holdings Inc's market cap moved from $1.65 Million to $ 1.65 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bio Path Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.65 Million USD |
| MoneyControl | $1.65 Million USD |
| MarketWatch | $1.65 Million USD |
| marketcap.company | $1.65 Million USD |
| Reuters | $1.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.